ASPG and acute lymphoblastic leukemia: The proposed study aims at the impact of early interruptions and the influence of the number of asparaginase doses effectively administered on the prognosis of patients with ALL treated at a pediatric teaching hospital located in Rio de Janeiro (Brazil) over 10 years.